Lazard Asset Management
VYGR icon

Lazard Asset Management’s Voyager Therapeutics VYGR Stock Holding History

Lazard Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-148
Closed – – 2596
2024
Q4 		$0 Sell
148
-6,337
-98% -$40.9K ﹤0.01% 2557
2024
Q3 		$37K Buy
6,485
+6,082
+1,509% +$44.2K ﹤0.01% 1958
2024
Q2 		$3K Sell
403
-18,339
-98% -$154K ﹤0.01% 2095
2024
Q1 		$174K Buy
18,742
+9,146
+95% +$77.2K ﹤0.01% 1350
2023
Q4 		$80K Sell
9,596
-13,429
-58% -$97.4K ﹤0.01% 1751
2023
Q3 		$178K Buy
23,025
+899
+4% +$8.21K ﹤0.01% 1428
2023
Q2 		$253K Buy
22,126
+10,260
+86% +$106K ﹤0.01% 1282
2023
Q1 		$91K Buy
11,866
+3,775
+47% +$30K ﹤0.01% 1569
2022
Q4 		$49K Sell
8,091
-2,192
-21% -$12.5K ﹤0.01% 1826
2022
Q3 		$60K Hold
10,283
– – ﹤0.01% 1716
2022
Q2 		$60K Sell
10,283
-7,395
-42% -$50K ﹤0.01% 1733
2022
Q1 		$134K Buy
17,678
+10,455
+145% +$46.6K ﹤0.01% 1330
2021
Q4 		$19K Buy
7,223
+1,253
+21% +$4.28K ﹤0.01% 2058
2021
Q3 		$15K Sell
5,970
-2,970
-33% -$9.65K ﹤0.01% 2055
2021
Q2 		$36K Buy
8,940
+8,762
+4,922% +$39.7K ﹤0.01% 1726
2021
Q1 		$0 Sell
178
-11,924
-99% -$81.3K ﹤0.01% 2044
2020
Q4 		$86K Buy
+12,102
New +$116K ﹤0.01% 1220
2019
Q4 		– Sell
-913
Closed -$15K – 1677
2019
Q3 		$15K Buy
+913
New +$19.2K ﹤0.01% 1163
2018
Q2 		– Sell
-25,658
Closed -$482K – 1121
2018
Q1 		$482K Buy
25,658
+5,479
+27% +$118K ﹤0.01% 779
2017
Q4 		$334K Buy
+20,179
New +$346K ﹤0.01% 822

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management's VYGR Position: Q1 2025 in Review

Lazard Asset Management sold out of Voyager Therapeutics (VYGR) in Q1 2025, closing a stake of 148 shares.

Lazard Asset Management first reported a position in VYGR in Q4 2017 and held it in 20 quarters. The position peaked at $482K in Q1 2018. 116 funds tracked by Wall St. Rank hold VYGR as of Q1 2025.

  • Lazard Asset Management reported no remaining Voyager Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 148 Voyager Therapeutics shares in Q1 2025.
  • Lazard Asset Management first reported a position in Voyager Therapeutics in Q4 2017 and held it in 20 quarters.
  • Lazard Asset Management's Voyager Therapeutics position peaked at $482K in Q1 2018.
  • 116 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.